Clinical Risk Management for Emerging Companies
Clinical Risk Management for Emerging Companies

Create an interactive hands-on learning environment specifically designed for emerging companies developing their clinical quality risk management approach. Identify the critical elements of an effective clinical quality approach to understand how to build a culture of quality from the ground up and lay a strong foundation for compliance and a confident state of inspection readiness, all utilizing limited resources

Join your peers in a candid sharing of experiences as we learn how to build and initiate effective clinical quality risk management strategies for emerging companies.

Kristen Hunter
VP, Content

Conference Chair

Sharon Reinhard
Sharon Reinhard
Vice President, Global Quality


The Avoca Group

Consortium Partner

WCG Avoca Quality Consortium


Sponsorship is a great way to enhance your brand’s visibility and help you connect with top-level decision-makers, innovators, and industry disruptors. There are a number of ways to maximize branding opportunities at the summit.

For more details on sponsorship and exhibition opportunities, please contact Michael Williams at

Top Reasons to Attend

Assess clinical risk using available resources to guide the development of your clinical risk management plan

Utilize mock inspections as a quality tool to focus risk mitigation efforts

Understand the current regulatory environment and the critical elements of changing regulations that impact clinical quality risk management

Implement quality measurement tools such as tolerance limits and key indicators to maintain compliance

Discuss best practices for vendor oversight and how to ensure your partners focus on quality

Identify best practices for building quality into your culture and processes from the start

Achieve a constant state of inspection readiness with already available tools and resources

Engage with your peers on real life examples of issue identification and management


This event is developed for professionals from pharmaceutical, biotechnology and medical device companies, CROs, clinical service and technology providers as well as those professionals from sites who have responsibilities in any the following areas:

  • Quality Management/ Clinical Quality Management
  • Clinical Quality Assurance/ QA/ CQA
  • Clinical Quality Control/ QC/ CQC
  • Quality Operations/ Quality Systems/ Quality Processes
  • Clinical Operations/ Management/ Research/ Development
  • Compliance/ Clinical Compliance/ Regulatory Compliance
  • Auditing
  • Inspection/ Inspection Readiness
  • Clinical Outsourcing/ Vendor Oversight and Management/ Strategic Partnerships/ Third-Party Management and Oversight
  • Clinical Risk/ Quality Risk/ Risk Assessment/ Risk Management
  • Site Monitoring/ Site Management/ Study Management/ Trial Management
  • Good Clinical Practice/ GCP
  • Clinical Data
  • Regulatory Affairs